package com.gcgenome.lims.interpretable.impl

import com.gcgenome.lims.JsonConfig
import com.gcgenome.lims.constants.Clazz
import com.gcgenome.lims.dto.Disease
import com.gcgenome.lims.dto.InterpretationPanel
import com.gcgenome.lims.dto.ParameterPanel
import com.gcgenome.lims.entity.Request
import com.gcgenome.lims.inserts.*
import io.mockk.every
import io.mockk.mockkClass
import org.junit.jupiter.api.DisplayName
import org.junit.jupiter.api.Test
import org.springframework.data.elasticsearch.core.document.Document
import reactor.core.publisher.Mono
import java.time.LocalDate
import kotlin.test.BeforeTest
import kotlin.test.assertEquals

internal class RareDiseaseTest{
    private val om = JsonConfig().objectMapper()
    private val requestDao = mockkClass(RequestDao::class)
    private val snvDao = mockkClass(SnvDao::class)
    private val insertList = listOf(`(S030,S032)PreSuffix`(), N046PostSuffix(), N048PostSuffix(), N046Negative(), N055PostSuffix(), N122Negative(), N122PostSuffix(), RareDiseaseNegativeDefault())
    private val interpreter = RareDisease(om, requestDao, snvDao, insertList)

    @BeforeTest
    internal fun prepareRequest() {
        every { requestDao.findById(202205181715082L, "N037") }
            .returns(
                Mono.just(
                    Request(
                        sample=202205181715082, service="N037",
                        organization = "L019030", organizationName = "충북대학교병원",
                        sampleType = "WB", age=110,
                        patientName = "홍길동", patientCode = "111111",
                        mrn = "10516425", sex="M", birth = LocalDate.of(2011, 11, 11),
                        register = true, cancel = false, delete = false
                    )
                )
            )
        every { requestDao.findById(202205091715044, "N046") }
            .returns(
                Mono.just(
                    Request(
                        sample=202205091715044, service="N046",
                        organization = "L014011", organizationName = "전북대학병원(진단)",
                        sampleType = "WB", age=55,
                        patientName = "강*숙", patientCode = "661028",
                        mrn = "01270796", sex="F", birth = LocalDate.of(1966, 10, 28),
                        register = true, cancel = false, delete = false
                    )
                )
            )
        every { requestDao.findById(202208291715038, "N046") }
            .returns(
                Mono.just(om.readValue("{ \"organization\": \"L052398\", \"organization_name\": \"영남대학교의료원(외래)\", \"organization_reg_no\": \"37100149\", \"department\": \"재활의학과(RM)\", \"physician\": null, \"ward\": null, \"patient_name\": \"김도원\", \"patient_code\": \"950610\", \"sex\": \"M\", \"birth\": \"1995-06-10\", \"age\": 27, \"mrn\": \"28315026\", \"sample\": 202208291715038, \"sample_type\": \" WB\", \"service\": \"N046\", \"service_name\": \"ATX_유전성 운동실조증 유전자 패널검사\", \"date_request\": \"2022-08-29 00:00:00.000000\", \"date_start\": \"2022-08-29 00:00:00.000000\", \"date_due\": \"2022-09-26 00:00:00.000000\", \"date_sampling\": \"2022-08-29 00:00:00.000000\", \"tat\": 21, \"info\": \"2022082951585\", \"barcode\": 82761165106, \"remark\": \"202208291165106\", \"register\": true, \"cancel\": false, \"delete\": false }", Request::class.java))
            )
        every { requestDao.findById(202011309715168, "N122") }
            .returns(
                Mono.just(om.readValue("{ \"organization\": \"G0Q0006\", \"organization_name\": \"결과지 검증\", \"organization_reg_no\": null, \"department\": null, \"physician\": \"TEST\", \"ward\": \"TEST\", \"patient_name\": \"음성(남)84\", \"patient_code\": null, \"sex\": \"M\", \"birth\": null, \"age\": null, \"mrn\": \"1111\", \"sample\": 202011309715168, \"sample_type\": \" WB\", \"service\": \"N122\", \"service_name\": \"미토콘드리아 DNA 패널검사\", \"date_request\": \"2020-11-30 00:00:00.000000\", \"date_start\": \"2020-11-30 00:00:00.000000\", \"date_due\": \"2020-12-23 00:00:00.000000\", \"date_sampling\": null, \"tat\": 21, \"info\": null, \"barcode\": 76399715168, \"remark\": null, \"register\": false, \"cancel\": false, \"delete\": false }", Request::class.java))
            )
        every { requestDao.findById(202206141715183, "N100") }
            .returns(
                Mono.just(om.readValue("{ \"organization\": \"L014011\", \"organization_name\": \"전북대학병원(진단)\", \"organization_reg_no\": \"35100010\", \"department\": null, \"physician\": null, \"ward\": null, \"patient_name\": \"김*진\", \"patient_code\": \"910712\", \"sex\": \"F\", \"birth\": \"1991-07-12\", \"age\": 30, \"mrn\": \"01945471\", \"sample\": 202206141715183, \"sample_type\": \" WB\", \"service\": \"N100\", \"service_name\": \"STK_유전성 뇌졸중 유전자 패널검사\", \"date_request\": \"2022-06-14 00:00:00.000000\", \"date_start\": \"2022-06-14 00:00:00.000000\", \"date_due\": \"2022-07-08 00:00:00.000000\", \"date_sampling\": \"2022-06-14 00:00:00.000000\", \"tat\": 21, \"info\": \"20220614X001300\", \"barcode\": 82001205323, \"remark\": \"202206141205323\", \"register\": true, \"cancel\": false, \"delete\": false }", Request::class.java))
            )
    }

    @BeforeTest
    internal fun prepareSnv() {
        every { snvDao.find("22SP001", "01db4ff4-9689-47b0-b0d9-1659788912c5:22SP001:001:hg19:15:089864088:G:A") }.returns(
            Mono.just(Document.parse(VUS1)))
        every { snvDao.find("22SS004", "01db4ff4-9689-47b0-b0d9-1659788912c5:22SS004:003:hg19:06:043017298:C:T") }
            .returns(Mono.just(Document.parse(testN046VUSVar1)))
        every { snvDao.find("22SS004", "01db4ff4-9689-47b0-b0d9-1659788912c5:22SS004:003:hg19:17:059885959:G:A") }
            .returns(Mono.just(Document.parse(testN046VUSVar2)))
        every { snvDao.find("22SS004", "01db4ff4-9689-47b0-b0d9-1659788912c5:22SS004:003:hg19:15:099251109:G:A") }
            .returns(Mono.just(Document.parse(testN046VUSVar3)))
        every { snvDao.find("22SS004", "01db4ff4-9689-47b0-b0d9-1659788912c5:22SS004:003:hg19:16:023619299:G:A") }
            .returns(Mono.just(Document.parse(testN046VUSVar4)))
        every { snvDao.find("22ST014", "01db4ff4-9689-47b0-b0d9-1659788912c5:22ST014:005:hg19:09:130581024:T:TGGTGTTGGAGGCCTGGAGGA") }
            .returns(Mono.just(Document.parse(testN100LPVVar1)))
        every { snvDao.find("22ST014", "01db4ff4-9689-47b0-b0d9-1659788912c5:22ST014:005:hg19:16:016263649:G:A") }
            .returns(Mono.just(Document.parse(testN100LPVVar2)))
        every { snvDao.find("22ST014", "01db4ff4-9689-47b0-b0d9-1659788912c5:22ST014:005:hg19:13:110855958:CA:C") }
            .returns(Mono.just(Document.parse(testN100LPVVar3)))
        every { snvDao.find("22ST014", "01db4ff4-9689-47b0-b0d9-1659788912c5:22ST014:005:hg19:17:078321902:C:T") }
            .returns(Mono.just(Document.parse(testN100LPVVar4)))
    }

    @Test
    @DisplayName("Panel Negative")
    internal fun testNegative() {
        val negative  = ParameterPanel(
            ParameterPanel.Sex.M,
            InterpretationPanel.builder().apply {
                meanDepth = "300.06"
                coverage = "100"
            }.build(), emptyMap(), null)
        val output = interpreter.interpret(202205181715082L, "N037", negative).block()
        assertEquals(
            InterpretationPanel(
                "NEGATIVE",
                "질환과 관련된 변이는 발견되지 않았습니다.",
                "R/O 유전성 부정맥",
                null,
                "", "", "",
                """
                    유전성 부정맥 유전자 패널 분석 결과, 질환과 관련된 변이는 발견되지 않았습니다.
                    
                    * 본 검사는 검사에 포함된 유전자들의 coding exon과 인접 intron 영역을 분석하며, deep intronic variant, exon deletion/duplication, genomic rearrangement를 포함한 copy number variant 검출은 제한적입니다. 또한, GC 함량이 높거나 염기서열 상동성이 높은 일부 유전자의 exon 부위는 본 검사법으로 변이를 검출하는데 한계가 있습니다. 검사의 기술적 한계에 대한 자세한 내용은 검사의 한계를 참조하십시오.
                """.trimIndent(),
                "300.06",
                "100",
                emptyList(), null,
                null, null
            ),
            output
        )
    }
    @Test
    @DisplayName("Panel Negative N046")
    internal fun testN046() {
        val negative  = ParameterPanel(ParameterPanel.Sex.M, InterpretationPanel.builder().apply {
            meanDepth = "300.06"
            coverage = "100"
        }.build(), emptyMap(), null)
        val output = interpreter.interpret(202205091715044, "N046", negative).block()
        kotlin.test.assertEquals(
            InterpretationPanel(
                "NEGATIVE",
                "질환과 관련된 변이는 발견되지 않았습니다.",
                "R/O 유전성 운동실조증",
                null, "", "", "",
                """
                    유전성 운동실조증 유전자 패널 분석 결과, 질환과 관련된 변이는 발견되지 않았습니다.

                    * 본 검사는 검사에 포함된 유전자들의 coding exon과 인접 intron 영역을 분석하며, deep intronic variant, exon deletion/duplication, genomic rearrangement를 포함한 copy number variant 검출은 제한적입니다. 또한, SCA1 (ATXN1), SCA2 (ATXN2), SCA3 (ATXN3), SCA6 (CACNA1A), SCA7 (ATXN7), SCA8 (ATXN8), SCA10 (ATXN10), SCA12 (PPP2R2B), SCA17 (TBP), SCA31, SCA36 (NOP56), DRPLA (ATN1) 등 Spinocerebellar ataxia (SCA)의 주요 원인인 반복서열 증가를 검출할 수 없으며, GC 함량이 높거나 염기서열 상동성이 높은 일부 유전자의 exon 부위는 본 검사법으로 변이를 검출하는데 한계가 있습니다. 검사의 기술적 한계에 대한 자세한 내용은 검사의 한계를 참조하십시오.
                """.trimIndent(),
                "300.06",
                "100",
                emptyList(), null, null, null
            ),
            output
        )
    }

    @Test
    @DisplayName("Panel VUS N046")
    internal fun testN046Vus() {
        val vus  = ParameterPanel(
            ParameterPanel.Sex.M, InterpretationPanel.builder().apply {
            meanDepth = "300.06"
            coverage = "100"
            appendVariant(
                InterpretationPanel.Variant("hg19:15:089864088:G:A", "01db4ff4-9689-47b0-b0d9-1659788912c5:22SP001:001",
                    "POLG",
                    "NM_002693.2:c.2890C>T", "p.Arg964Cys",
                    "0/1", null, null, null,
                    null, null, Clazz.VUS
                )
            )
        }.build(),
            mapOf(Pair("POLG", listOf(
                Disease("Mitochondrial DNA depletion syndrome 4B (MNGIE type)", "MDDS4B", listOf("AR")),
                Disease("Mitochondrial DNA depletion syndrome 4A (Alpers type)", "MDDS4A", listOf("AR")),
                Disease("Progressive external ophthalmoplegia", "PEO", listOf("AD"))
            ))
            ),"상염색체 열성 질환에서 한 개의 Heterozygous VUS 변이만이 발견된 경우, 1) 이 변이가 질환과 관련이 없는 변이일 가능성, 2) 실제 질환과 관련이 있지만 보인자일 가능성, 3) 실제 이 유전자와 관련된 질환을 가지고 있지만 나머지 하나의 대립 유전자가 본 검사로 검출되지 않는 종류의 변이(large deletion or insertion, deep intronic variant, etc.)를 동반할 가능성 등이 있습니다. 상염색체 열성 유전 질환에서 한 개의 VUS가 발견된 경우, 가족검사를 시행하더라도 변이의 Pathogenicity를 판단하는데 도움이 되지 않으므로 가족검사가 권장되지 않습니다. Clinical correlation이 권장되며, 임상적으로 필요하다고 판단될 경우 deep intronic variant, large deletion/insertion 등을 검출하기 위한 추가 검사(Diagnostic Genome Sequencing 등)를 고려하시기 바랍니다.")
        val output = interpreter.interpret(202205091715044, "N046", vus).block()
        kotlin.test.assertEquals(
            InterpretationPanel(
                "INCONCLUSIVE",
                "VUS가 발견되었습니다.",
                "R/O 유전성 운동실조증",
                null,
                "NM_002693.2(POLG)",
                "MDDS4B, Mitochondrial DNA depletion syndrome 4B (MNGIE type); MDDS4A, Mitochondrial DNA depletion syndrome 4A (Alpers type); PEO, Progressive external ophthalmoplegia",
                "Het, Heterozygous; AR, Autosomal recessive; AD, Autosomal dominant; VUS, Variant of Uncertain Significance",
                """
                    유전성 운동실조증 유전자 패널 분석 결과, POLG 유전자에서 VUS가 발견되었습니다.
                    
                    POLG 유전자의 c.2890C>T (p.Arg964Cys) 변이는 전체 인구 집단(gnomAD)에서의 minor allele frequency (MAF)가 0.0672%이며 한국인 인구 집단(KRGDB)에서는 0.3182%인 변이로, in-silico prediction(SIFT, PolyPhen, MutationTaster)에서는 Deleterious로 예측되었습니다. 이 변이는 기존에 Lactic acidosis 환자에서 보고된 바 있으나(PMID: 17436221), 질환 관련성에 대한 근거가 불충분하여 VUS로 분류되며, ClinVar에서 PV(5) 또는 LPV(3) 또는 VUS(2) 또는 BV(1)로 분류되어 있습니다(ID: 206537).
                    
                    POLG 유전자는 MDDS4B, MDDS4A, PEO 관련 유전자로 AR 또는 AD 유전 양상을 보입니다.
                    
                    상염색체 열성 질환에서 한 개의 Heterozygous VUS 변이만이 발견된 경우, 1) 이 변이가 질환과 관련이 없는 변이일 가능성, 2) 실제 질환과 관련이 있지만 보인자일 가능성, 3) 실제 이 유전자와 관련된 질환을 가지고 있지만 나머지 하나의 대립 유전자가 본 검사로 검출되지 않는 종류의 변이(large deletion or insertion, deep intronic variant, etc.)를 동반할 가능성 등이 있습니다. 상염색체 열성 유전 질환에서 한 개의 VUS가 발견된 경우, 가족검사를 시행하더라도 변이의 Pathogenicity를 판단하는데 도움이 되지 않으므로 가족검사가 권장되지 않습니다. Clinical correlation이 권장되며, 임상적으로 필요하다고 판단될 경우 deep intronic variant, large deletion/insertion 등을 검출하기 위한 추가 검사(Diagnostic Genome Sequencing 등)를 고려하시기 바랍니다.
                    
                    * 본 검사는 검사에 포함된 유전자들의 coding exon과 인접 intron 영역을 분석하며, deep intronic variant, exon deletion/duplication, genomic rearrangement를 포함한 copy number variant 검출은 제한적입니다. 또한, SCA1 (ATXN1), SCA2 (ATXN2), SCA3 (ATXN3), SCA6 (CACNA1A), SCA7 (ATXN7), SCA8 (ATXN8), SCA10 (ATXN10), SCA12 (PPP2R2B), SCA17 (TBP), SCA31, SCA36 (NOP56), DRPLA (ATN1) 등 Spinocerebellar ataxia (SCA)의 주요 원인인 반복서열 증가를 검출할 수 없으며, GC 함량이 높거나 염기서열 상동성이 높은 일부 유전자의 exon 부위는 본 검사법으로 변이를 검출하는데 한계가 있습니다. 검사의 기술적 한계에 대한 자세한 내용은 검사의 한계를 참조하십시오.
                """.trimIndent().replace("\\n|\\r\\n", System.getProperty("line.separator")),
                "300.06",
                "100",
                listOf(
                    InterpretationPanel.Variant(
                        "hg19:15:089864088:G:A",
                        "01db4ff4-9689-47b0-b0d9-1659788912c5:22SP001:001",
                        "POLG",
                        "c.2890C>T",
                        "p.Arg964Cys",
                        "Het",
                        "MDDS4B, MDDS4A, PEO",
                        "Mitochondrial DNA depletion syndrome 4B (MNGIE type);Mitochondrial DNA depletion syndrome 4A (Alpers type);Progressive external ophthalmoplegia",
                        "AR, AD",
                        null, null, Clazz.VUS
                    )
                ), null, null, null
            ),output
        )
    }

    @Test
    @DisplayName("N046 변이 4개의 VUS")
    internal fun testN046VUS() {
        val prev = om.readValue("{\"sex\": \"M\",\"disease\":{\"CUL7\":[{\"full_name\":\"3 M syndrome 1\",\"abbreviation\":\"3-MS1\",\"inheritance\":[\"AR\"]}],\"BRIP1\":[{\"full_name\":\"Susceptibility to breast cancer\",\"abbreviation\":\"BCs\",\"inheritance\":[\"AD\"]}],\"IGF1R\":[{\"full_name\":\"Insulin like growth factor I, resistance to\",\"abbreviation\":\"GR\",\"inheritance\":[\"AD\",\"AR\"]}],\"PALB2\":[{\"full_name\":\"Susceptibility to breast cancer\",\"abbreviation\":\"BCs\",\"inheritance\":[\"AD\"]}]},\"sex\":\"M\",\"suffix\":\"\",\"previous\":{\"result\":\"INCONCLUSIVE\",\"result_text\":\"VUS 4개가 발견되었습니다.\",\"reason_for_referral\":\"R/O 유전성 저신장증\",\"variants\":[{\"snv\":\"hg19:06:043017298:C:T\",\"analysis\":\"01db4ff4-9689-47b0-b0d9-1659788912c5:22SS004:003\",\"gene\":\"CUL7\",\"hgvsc\":\"c.1672G>A\",\"hgvsp\":\"p.Asp558Asn\",\"zygosity\":\"Het\",\"disease\":\"3-MS1\",\"inheritance\":\"AR\",\"class\":\"VUS\",\"disease_full_name\":\"3 M syndrome 1\",\"mim\":\"3-M syndrome 1, 273750 (3), Autosomal recessive\"},{\"snv\":\"hg19:17:059885959:G:A\",\"analysis\":\"01db4ff4-9689-47b0-b0d9-1659788912c5:22SS004:003\",\"gene\":\"BRIP1\",\"hgvsc\":\"c.787C>T\",\"hgvsp\":\"p.Leu263Phe\",\"zygosity\":\"Het\",\"disease\":\"BCs\",\"inheritance\":\"AD\",\"class\":\"VUS\",\"disease_full_name\":\"Susceptibility to breast cancer\",\"mim\":\"Fanconi anemia, complementation group J, 609054 (3) | {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant\"},{\"snv\":\"hg19:15:099251109:G:A\",\"analysis\":\"01db4ff4-9689-47b0-b0d9-1659788912c5:22SS004:003\",\"gene\":\"IGF1R\",\"hgvsc\":\"c.413G>A\",\"hgvsp\":\"p.Arg138Gln\",\"zygosity\":\"Het\",\"disease\":\"GR\",\"inheritance\":\"AD, AR\",\"class\":\"VUS\",\"disease_full_name\":\"Insulin like growth factor I, resistance to\",\"mim\":\"Insulin-like growth factor I, resistance to, 270450 (3), Autosomal dominant, Autosomal recessive\"},{\"snv\":\"hg19:16:023619299:G:A\",\"analysis\":\"01db4ff4-9689-47b0-b0d9-1659788912c5:22SS004:003\",\"gene\":\"PALB2\",\"hgvsc\":\"c.3236C>T\",\"hgvsp\":\"p.Ala1079Val\",\"zygosity\":\"Het\",\"disease\":\"BCs\",\"inheritance\":\"AD\",\"class\":\"VUS\",\"disease_full_name\":\"Susceptibility to breast cancer\",\"mim\":\"{Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant | {Pancreatic cancer, susceptibility to, 3}, 613348 (3) | Fanconi anemia, complementation group N, 610832 (3)\"}],\"abbreviation_reference\":\"\",\"abbreviation_disease\":\"\",\"abbreviation\":\"\",\"interpretation\":\"\",\"coverage\":\"\",\"mean_depth\":\"\"}}", ParameterPanel::class.java)
        val result = interpreter.interpret(202208021715075, "N046", prev).block()
        println(om.writeValueAsString(result))
        assertEquals(
            om.readValue("{\"result\":\"INCONCLUSIVE\",\"result_text\":\"VUS 4개가 발견되었습니다.\",\"reason_for_referral\":\"R/O 유전성 운동실조증\",\"clinical_information\":null,\"abbreviation_reference\":\"NM_014780.4(CUL7); NM_032043.3(BRIP1); NM_000875.5(IGF1R); NM_024675.4(PALB2)\",\"abbreviation_disease\":\"3-MS1, 3 M syndrome 1; BCs, Susceptibility to breast cancer; GR, Insulin like growth factor I, resistance to\",\"abbreviation\":\"Het, Heterozygous; AR, Autosomal recessive; AD, Autosomal dominant; VUS, Variant of Uncertain Significance\",\"interpretation\":\"유전성 운동실조증 유전자 패널 분석 결과, CUL7, BRIP1, IGF1R, PALB2 유전자에서 VUS가 발견되었습니다.\\n\\nCUL7 유전자의 c.1672G>A (p.Asp558Asn) 변이는 전체 인구 집단(gnomAD)에서의 minor allele frequency (MAF)가 0.0004%이며 한국인 인구 집단(KRGDB)에서는 보고된 바 없는 변이로, in-silico prediction(SIFT, PolyPhen, MutationTaster)에서는 Deleterious로 예측되었습니다. 이 변이는 질환 관련성에 대한 근거가 불충분하여 VUS로 분류됩니다.\\n\\nCUL7 유전자는 3-MS1 관련 유전자로 AR 유전 양상을 보입니다.\\n\\nBRIP1 유전자의 c.787C>T (p.Leu263Phe) 변이는 전체 인구 집단(gnomAD)에서의 MAF가 0.0032%이며 한국인 인구 집단(KRGDB)에서는 0.0455%인 변이로, in-silico prediction(SIFT, PolyPhen, MutationTaster)에서는 Deleterious로 예측되었습니다. 이 변이는 질환 관련성에 대한 근거가 불충분하여 VUS로 분류되며, ClinVar에서 VUS로 분류되어 있습니다(ID: 407869).\\n\\nBRIP1 유전자는 BCs 관련 유전자로 AD 유전 양상을 보입니다.\\n\\nIGF1R 유전자의 c.413G>A (p.Arg138Gln) 변이는 일반 인구 집단(gnomAD, KRGDB)에서 보고된 바 없는 매우 드문 변이로, in-silico prediction(SIFT, PolyPhen, MutationTaster)에서는 Deleterious로 예측되었습니다. 이 변이는 기존에 Growth retardation 환자에서 보고된 바 있으나(PMID: 14657428), 질환 관련성에 대한 근거가 불충분하여 VUS로 분류되며, ClinVar에서 protective로 분류되어 있습니다(ID: 14790).\\n\\nIGF1R 유전자는 GR 관련 유전자로 AD 또는 AR 유전 양상을 보입니다.\\n\\nPALB2 유전자의 c.3236C>T (p.Ala1079Val) 변이는 전체 인구 집단(gnomAD)에서의 MAF가 0.0004%이며 한국인 인구 집단(KRGDB)에서는 0.0909%인 변이로, in-silico prediction에서는 서로 다르게 예측되었습니다(SIFT, PolyPhen: Deleterious, MutationTaster: Tolerated). 이 변이는 질환 관련성에 대한 근거가 불충분하여 VUS로 분류되며, ClinVar에서 VUS로 분류되어 있습니다(ID: 460984).\\n\\nPALB2 유전자는 BCs 관련 유전자로 AD 유전 양상을 보입니다.\\n\\n* 본 검사는 검사에 포함된 유전자들의 coding exon과 인접 intron 영역을 분석하며, deep intronic variant, exon deletion/duplication, genomic rearrangement를 포함한 copy number variant 검출은 제한적입니다. 또한, SCA1 (ATXN1), SCA2 (ATXN2), SCA3 (ATXN3), SCA6 (CACNA1A), SCA7 (ATXN7), SCA8 (ATXN8), SCA10 (ATXN10), SCA12 (PPP2R2B), SCA17 (TBP), SCA31, SCA36 (NOP56), DRPLA (ATN1) 등 Spinocerebellar ataxia (SCA)의 주요 원인인 반복서열 증가를 검출할 수 없으며, GC 함량이 높거나 염기서열 상동성이 높은 일부 유전자의 exon 부위는 본 검사법으로 변이를 검출하는데 한계가 있습니다. 검사의 기술적 한계에 대한 자세한 내용은 검사의 한계를 참조하십시오.\",\"mean_depth\":\"\",\"coverage\":\"\",\"variants\":[{\"snv\":\"hg19:06:043017298:C:T\",\"analysis\":\"01db4ff4-9689-47b0-b0d9-1659788912c5:22SS004:003\",\"gene\":\"CUL7\",\"hgvsc\":\"c.1672G>A\",\"hgvsp\":\"p.Asp558Asn\",\"zygosity\":\"Het\",\"disease\":\"3-MS1\",\"disease_full_name\":\"3 M syndrome 1\",\"inheritance\":\"AR\",\"class\":\"VUS\"},{\"snv\":\"hg19:17:059885959:G:A\",\"analysis\":\"01db4ff4-9689-47b0-b0d9-1659788912c5:22SS004:003\",\"gene\":\"BRIP1\",\"hgvsc\":\"c.787C>T\",\"hgvsp\":\"p.Leu263Phe\",\"zygosity\":\"Het\",\"disease\":\"BCs\",\"disease_full_name\":\"Susceptibility to breast cancer\",\"inheritance\":\"AD\",\"class\":\"VUS\"},{\"snv\":\"hg19:15:099251109:G:A\",\"analysis\":\"01db4ff4-9689-47b0-b0d9-1659788912c5:22SS004:003\",\"gene\":\"IGF1R\",\"hgvsc\":\"c.413G>A\",\"hgvsp\":\"p.Arg138Gln\",\"zygosity\":\"Het\",\"disease\":\"GR\",\"disease_full_name\":\"Insulin like growth factor I, resistance to\",\"inheritance\":\"AD, AR\",\"class\":\"VUS\"},{\"snv\":\"hg19:16:023619299:G:A\",\"analysis\":\"01db4ff4-9689-47b0-b0d9-1659788912c5:22SS004:003\",\"gene\":\"PALB2\",\"hgvsc\":\"c.3236C>T\",\"hgvsp\":\"p.Ala1079Val\",\"zygosity\":\"Het\",\"disease\":\"BCs\",\"disease_full_name\":\"Susceptibility to breast cancer\",\"inheritance\":\"AD\",\"class\":\"VUS\"}],\"recommendation\":null,\"addendum\":null,\"incidental_findings\":null,\"authors\":[],\"revision\":false}", InterpretationPanel::class.java),
            result
        )
    }

    @Test
    @DisplayName("N100 변이 4개, LPV 1 VUS 3")
    internal fun testN100LPV() {
        val prev = om.readValue("{\"disease\":{\"ENG\":[{\"full_name\":\"Telangiectasia, hereditary hemorrhagic, type 1\",\"abbreviation\":\"HHT1\",\"inheritance\":[\"AD\"]}],\"ABCC6\":[{\"full_name\":\"Pseudoxanthoma elasticum\",\"abbreviation\":\"PE\",\"inheritance\":[\"AR\"]}],\"COL4A1\":[{\"full_name\":\"?Retinal arteries, tortuosity of\",\"abbreviation\":\"ATO\",\"inheritance\":[\"AD\"]}],\"RNF213\":[{\"full_name\":\" Moyamoya disease 2, susceptibility to\",\"abbreviation\":\"MMD\",\"inheritance\":[\"AD\"]}]},\"sex\":\"F\",\"suffix\":\"\",\"previous\":{\"result\":\"POSITIVE\",\"result_text\":\"LPV 1개와 VUS 3개가 발견되었습니다.\",\"reason_for_referral\":\"R/O 유전성 뇌졸중\",\"variants\":[{\"snv\":\"hg19:09:130581024:T:TGGTGTTGGAGGCCTGGAGGA\",\"analysis\":\"01db4ff4-9689-47b0-b0d9-1659788912c5:22ST014:005\",\"gene\":\"ENG\",\"hgvsc\":\"c.1379_1398dup\",\"hgvsp\":\"p.Ile467SerfsTer31\",\"zygosity\":\"Het\",\"disease\":\"HHT1\",\"inheritance\":\"AD\",\"class\":\"LPV\",\"disease_full_name\":null,\"mim\":\"Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3), Autosomal dominant\"},{\"snv\":\"hg19:16:016263649:G:A\",\"analysis\":\"01db4ff4-9689-47b0-b0d9-1659788912c5:22ST014:005\",\"gene\":\"ABCC6\",\"hgvsc\":\"c.2849C>T\",\"hgvsp\":\"p.Ala950Val\",\"zygosity\":\"Het\",\"disease\":\"PXE\",\"inheritance\":\"AR\",\"class\":\"VUS\",\"disease_full_name\":null,\"mim\":\"Pseudoxanthoma elasticum, 264800 (3), Autosomal recessive | Arterial calcification, generalized, of infancy, 2, 614473 (3), Autosomal recessive | Pseudoxanthoma elasticum, forme fruste, 177850 (3), Autosomal dominant\"},{\"snv\":\"hg19:13:110855958:CA:C\",\"analysis\":\"01db4ff4-9689-47b0-b0d9-1659788912c5:22ST014:005\",\"gene\":\"COL4A1\",\"hgvsc\":\"c.958-5del\",\"hgvsp\":\"p.?\",\"zygosity\":\"Het\",\"disease\":\"BSVD, HANAC\",\"inheritance\":\"AD\",\"class\":\"VUS\",\"disease_full_name\":null,\"mim\":\"?Retinal arteries, tortuosity of, 180000 (3), Autosomal dominant | {Hemorrhage, intracerebral, susceptibility to}, 614519 (3) | Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3), Autosomal dominant | Microangiopathy and leukoencephalopathy, pontine, autosomal dominant, 618564 (3), Autosomal dominant | Brain small vessel disease with or without ocular anomalies, 175780 (3), Autosomal dominant\"},{\"snv\":\"hg19:17:078321902:C:T\",\"analysis\":\"01db4ff4-9689-47b0-b0d9-1659788912c5:22ST014:005\",\"gene\":\"RNF213\",\"hgvsc\":\"c.9767C>T\",\"hgvsp\":\"p.Ser3256Leu\",\"zygosity\":\"Het\",\"disease\":\"MMD\",\"inheritance\":\"AD\",\"class\":\"VUS\",\"disease_full_name\":null,\"mim\":\"{Moyamoya disease 2, susceptibility to}, 607151 (3), Autosomal dominant, Autosomal recessive\"}],\"abbreviation_reference\":\"\",\"abbreviation_disease\":\"\",\"abbreviation\":\"\",\"interpretation\":\"\",\"coverage\":\"\",\"mean_depth\":\"\"}}", ParameterPanel::class.java)
        val result = interpreter.interpret(202206141715183, "N100", prev).block()
        println(om.writeValueAsString(result))
        assertEquals(
            om.readValue("{\"result\":\"POSITIVE\",\"result_text\":\"LPV 1개와 VUS 3개가 발견되었습니다.\",\"reason_for_referral\":\"R/O 유전성 뇌졸중\",\"clinical_information\":null,\"abbreviation_reference\":\"NM_000118.3(ENG); NM_001171.5(ABCC6); NM_001845.6(COL4A1); NM_001256071.3(RNF213)\",\"abbreviation_disease\":\"HHT1, Telangiectasia, hereditary hemorrhagic, type 1; PE, Pseudoxanthoma elasticum; ATO, ?Retinal arteries, tortuosity of; MMD,  Moyamoya disease 2, susceptibility to\",\"abbreviation\":\"Het, Heterozygous; AD, Autosomal dominant; AR, Autosomal recessive; LPV, Likely Pathogenic Variant; VUS, Variant of Uncertain Significance\",\"interpretation\":\"유전성 뇌졸중 유전자 패널 분석 결과, ENG 유전자에서 LPV가 발견되었고, ABCC6, COL4A1, RNF213 유전자에서 VUS가 발견되었습니다.\\n\\nENG 유전자의 c.1379_1398dup (p.Ile467SerfsTer31) 변이는 일반 인구 집단(gnomAD, KRGDB)에서 보고된 바 없는 매우 드문 변이입니다.\\n\\nENG 유전자는 HHT1 관련 유전자로 AD 유전 양상을 보입니다.\\n\\nABCC6 유전자의 c.2849C>T (p.Ala950Val) 변이는 전체 인구 집단(gnomAD)에서의 MAF가 0.0090%이며 한국인 인구 집단(KRGDB)에서는 0.1818%인 변이로, in-silico prediction(SIFT, PolyPhen, MutationTaster)에서는 Tolerated로 예측되었습니다. 이 변이는 기존에 Angioid streaks 환자에서 보고된 바 있으나(PMID: 19284998), 질환 관련성에 대한 근거가 불충분하여 VUS로 분류됩니다.\\n\\nABCC6 유전자는 PE 관련 유전자로 AR 유전 양상을 보입니다.\\n\\nCOL4A1 유전자의 c.958-5del (p.?) 변이는 전체 인구 집단(gnomAD)에서의 MAF가 0.0035%이며 한국인 인구 집단(KRGDB)에서는 0.0909%인 변이입니다. 이 변이는 질환 관련성에 대한 근거가 불충분하여 VUS로 분류됩니다.\\n\\nCOL4A1 유전자는 ATO 관련 유전자로 AD 유전 양상을 보입니다.\\n\\nRNF213 유전자의 c.9767C>T (p.Ser3256Leu) 변이는 전체 인구 집단(gnomAD)에서의 MAF가 0.0156%이며 한국인 인구 집단(KRGDB)에서는 0.4545%인 변이로, in-silico prediction(SIFT, PolyPhen, MutationTaster)에서는 Tolerated로 예측되었습니다. 이 변이는 질환 관련성에 대한 근거가 불충분하여 VUS로 분류되며, ClinVar에서 VUS로 분류되어 있습니다(ID: 597193).\\n\\nRNF213 유전자는 MMD 관련 유전자로 AD 유전 양상을 보입니다.\",\"mean_depth\":\"\",\"coverage\":\"\",\"variants\":[{\"snv\":\"hg19:09:130581024:T:TGGTGTTGGAGGCCTGGAGGA\",\"analysis\":\"01db4ff4-9689-47b0-b0d9-1659788912c5:22ST014:005\",\"gene\":\"ENG\",\"hgvsc\":\"c.1379_1398dup\",\"hgvsp\":\"p.Ile467SerfsTer31\",\"zygosity\":\"Het\",\"disease\":\"HHT1\",\"disease_full_name\":\"Telangiectasia, hereditary hemorrhagic, type 1\",\"inheritance\":\"AD\",\"class\":\"LPV\"},{\"snv\":\"hg19:16:016263649:G:A\",\"analysis\":\"01db4ff4-9689-47b0-b0d9-1659788912c5:22ST014:005\",\"gene\":\"ABCC6\",\"hgvsc\":\"c.2849C>T\",\"hgvsp\":\"p.Ala950Val\",\"zygosity\":\"Het\",\"disease\":\"PE\",\"disease_full_name\":\"Pseudoxanthoma elasticum\",\"inheritance\":\"AR\",\"class\":\"VUS\"},{\"snv\":\"hg19:13:110855958:CA:C\",\"analysis\":\"01db4ff4-9689-47b0-b0d9-1659788912c5:22ST014:005\",\"gene\":\"COL4A1\",\"hgvsc\":\"c.958-5del\",\"hgvsp\":\"p.?\",\"zygosity\":\"Het\",\"disease\":\"ATO\",\"disease_full_name\":\"?Retinal arteries, tortuosity of\",\"inheritance\":\"AD\",\"class\":\"VUS\"},{\"snv\":\"hg19:17:078321902:C:T\",\"analysis\":\"01db4ff4-9689-47b0-b0d9-1659788912c5:22ST014:005\",\"gene\":\"RNF213\",\"hgvsc\":\"c.9767C>T\",\"hgvsp\":\"p.Ser3256Leu\",\"zygosity\":\"Het\",\"disease\":\"MMD\",\"disease_full_name\":\" Moyamoya disease 2, susceptibility to\",\"inheritance\":\"AD\",\"class\":\"VUS\"}],\"recommendation\":null,\"addendum\":null,\"incidental_findings\":null,\"authors\":[],\"revision\":false}", InterpretationPanel::class.java),
            result
        )
    }

    @Test
    @DisplayName("N122 Negative")
    internal fun testN122(){
        val prev = om.readValue("{\"sex\":\"M\",\"suffix\":\"\",\"previous\":{\"result\":\"NEGATIVE\",\"result_text\":\"질환과 관련된 변이는 발견되지 않았습니다.\",\"reason_for_referral\":\"R/O 유전성 미토콘드리아 질환\",\"variants\":[],\"abbreviation_reference\":\"\",\"abbreviation_disease\":\"\",\"abbreviation\":\"\",\"interpretation\":\"미토콘드리아 유전자 패널 분석 결과, 질환과 관련된 변이는 발견되지 않았습니다.\\n\\n본 검사는 Mitochondrial DNA (mtDNA) 및 Mitochondrial disease와 관련된 Nuclear DNA 유전자를 분석하여 Mitochondrial disease 관련 변이를 검출합니다. 단, Mitochondrial DNA의 중복과 대규모 결실은 검출할 수 없습니다. 검사의 기술적 한계에 대한 자세한 내용은 검사의 한계를 참조하십시오.\\n\\n\",\"coverage\":\"99.9\",\"mean_depth\":\"200\"}}", ParameterPanel::class.java)
        val result = interpreter.interpret(202011309715168, "N122", prev).block()
        assertEquals(
            om.readValue("{\"result\":\"NEGATIVE\",\"result_text\":\"질환과 관련된 변이는 발견되지 않았습니다.\",\"reason_for_referral\":\"R/O 유전성 미토콘드리아 질환\",\"clinical_information\":null,\"abbreviation_reference\":\"\",\"abbreviation_disease\":\"\",\"abbreviation\":\"\",\"interpretation\":\"미토콘드리아 유전자 패널 분석 결과, 질환과 관련된 변이는 발견되지 않았습니다.\\n\\n본 검사는 Mitochondrial DNA (mtDNA) 및 Mitochondrial disease와 관련된 Nuclear DNA 유전자를 분석하여 Mitochondrial disease 관련 변이를 검출합니다. 단, Mitochondrial DNA의 중복과 대규모 결실은 검출할 수 없습니다. 검사의 기술적 한계에 대한 자세한 내용은 검사의 한계를 참조하십시오.\",\"mean_depth\":\"200\",\"coverage\":\"99.9\",\"variants\":[],\"recommendation\":null,\"addendum\":null,\"incidental_findings\":null,\"authors\":[],\"revision\":false}", InterpretationPanel::class.java),
            result
        )
    }
    val VUS1 = "{\"hgmd.mut\":\"ALT\",\"mgi_wes151_af\":\"0.00662\",\"ge_green\":\"White matter disorders - childhood onset | White matter disorders - childhood onset | White matter disorders - childhood onset | White matter disorders - childhood onset | White matter disorders - childhood onset | White matter disorders - childhood onset | White matter disorders - childhood onset | White matter disorders - childhood onset | White matter disorders and cerebral calcification - narrow panel | Severe Paediatric Disorders | Rhabdomyolysis and metabolic muscle disorders | Rhabdomyolysis and metabolic muscle disorders | Possible mitochondrial disorder - nuclear genes | Paediatric disorders | Paediatric disorders | Paediatric disorders | Paediatric disorders | Paediatric disorders | Paediatric disorders | Mitochondrial liver disease | Mitochondrial DNA maintenance disorder | Mitochondrial disorders | Mitochondrial disorders | Intellectual disability | Inherited white matter disorders | Inborn errors of metabolism | Hypotonic infant | Hypotonic infant | Hypotonic infant | Hypotonic infant | Hypotonic infant | Hypotonic infant | Hyperammonaemia | Hyperammonaemia | Hereditary neuropathy | Hereditary ataxia | Hereditary ataxia and cerebellar anomalies - childhood onset | Hereditary ataxia - adult onset | Genetic epilepsy syndromes | Gastrointestinal neuromuscular disorders | DDG2P | DDG2P | Cholestasis | Cholestasis | Cataracts | Ataxia and cerebellar anomalies - narrow panel | Cataracts | Gastrointestinal neuromuscular disorders | Genetic epilepsy syndromes | Hereditary ataxia - adult onset | Hereditary ataxia and cerebellar anomalies - childhood onset | Hereditary ataxia | Hereditary neuropathy | Inborn errors of metabolism | Inherited white matter disorders | Intellectual disability | Mitochondrial DNA maintenance disorder | Mitochondrial liver disease | Neonatal cholestasis | Neonatal cholestasis | Neuromuscular disorders | Neuromuscular disorders | Possible mitochondrial disorder - nuclear genes | Primary ovarian insufficiency | Primary ovarian insufficiency | Severe Paediatric Disorders | Undiagnosed metabolic disorders | Undiagnosed metabolic disorders | White matter disorders and cerebral calcification - narrow panel\",\"af_1000g_eas\":\"0.0129\",\"hgvsc\":\"[\\\"NM_002693.2:c.2890C>T\\\",\\\"\\\",\\\"NM_001126131.2:c.2890C>T\\\",\\\"\\\"]\",\"reference\":\"hg19\",\"ref\":\"G\",\"gnomad.exome.eas_kor\":\"4.97643e-03\",\"cadd.raw\":\"5.176180\",\"dbsnp\":\"rs201477273\",\"af_1000g_sas\":\"0.002\",\"vaf\":\"0.471739130435\",\"mutationtaster.score\":\"1&1\",\"class_order\":\"75\",\"hgvsp\":\"[\\\"p.Arg964Cys\\\",\\\"p.?\\\",\\\"p.Arg964Cys\\\",\\\"p.?\\\"]\",\"splicing_distance\":\"0\",\"organism\":\"homo sapiens\",\"gnomad.genome.eas\":\"1.15385e-02\",\"so_term\":\"[\\\"missense_variant\\\"]\",\"alt\":\"A\",\"cadd.pred\":\"35\",\"sift.pred\":\"deleterious\",\"gene.refgene\":\"POLG\",\"spliceai_ds_max\":\"0.0\",\"lrt.score\":\"0.000000\",\"exac.eas\":\"0.00925\",\"analysis\":\"01db4ff4-9689-47b0-b0d9-1659788912c5:22SP001:001\",\"gnomad.total\":\"0.000672442594637\",\"tags\":\"[\\\"candidate\\\",\\\"all\\\"]\",\"genotype\":\"0/1\",\"intervar.class\":\"Uncertain_significance\",\"krgdb_af\":\"0.00318182\",\"gmd2256_af\":\"0.0051\",\"clinvar.updated_class\":\"Conflicting interpretations of pathogenicity\",\"hgmd.tag\":\"DM\",\"intervar.evidence.pv\":\"PM1&PP3&PP5\",\"hgmd.pmid\":\"17436221\",\"polyphen.pred\":\"probably_damaging\",\"insilico_sanger\":\"Y\",\"wes300_af\":\"0.00667\",\"polyphen.score\":\"1\",\"hgmd.hgvsp\":\"[\\\"p.Arg964Cys\\\"]\",\"hgmd.web.literature\":\"{1. Yamanaka (2007) J Infect Dis 195: 1419 PubMed: 17436221 Novel mutation of human DNA polymerase gamma associated with mitochondrial toxicity induced by anti-HIV treatment. | Primary literature report | dm:original reference supporting inclusion | No comments}|{2. Bailey (2009) Antimicrob Agents Chemother 53: 2610 PubMed: 19364868 R964C mutation of DNA polymerase gamma imparts increased stavudine toxicity by decreasing nucleoside analog discrimination and impairing polymerase activity. | Functional characterisation | . | None}|{3. Kasiviswanathan (2010) Methods 51: 379 PubMed: 20176107 Purification and functional characterization of human mitochondrial DNA polymerase gamma harboring disease mutations. | Functional characterisation | . | None}|{4. Ohba (2013) Neurogenetics 14: 225 PubMed: 24091540 Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood. | Additional phenotype | dm:additional reference supporting inclusion | Mitochondrial DNA depletion syndrome\",\"effect_level\":\"MED\",\"intervar.evidence.bv\":\"BS1\",\"clinvar.clndbn\":\"[\\\"Seizure&Spinocerebellar_atrophy&Progressive_sclerosing_poliodystrophy&Mitochondrial_DNA_depletion_syndrome_4b&Hereditary_spastic_paraplegia&not_provided\\\"]\",\"fathmm.pred\":\"D&D\",\"strand\":\"true\",\"sift.score\":\"0\",\"pos\":\"89864088\",\"lrt.pred\":\"D\",\"ge_amber\":\"Optic neuropathy | Optic neuropathy | Hereditary neuropathy NOT PMP22 copy number | Hereditary neuropathy NOT PMP22 copy number | .\",\"wes_als312_af\":\"0.00321\",\"hgmd.hgvsc\":\"[\\\"NM_002693.2:c.2890C>T\\\"]\",\"clinvar.updated_review\":\"criteria provided, conflicting interpretations\",\"gnomad.exome.eas\":\"8.80914e-03\",\"class\":\"VUS\",\"exac.sas\":\"0.000182\",\"fathmm.score\":\"-4.27&-4.27\",\"clinvar.class\":\"Conflicting_interpretations_of_pathogenicity|Pathogenic(5)&_Likely_pathogenic(3)&_Uncertain_significance(2)&_Benign(1)\",\"clinvar.id\":\"206537\",\"mim.disease\":\"Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3), Autosomal recessive | Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3), Autosomal recessive | Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3), Autosomal recessive | Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3), Autosomal dominant | Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3), Autosomal recessive\",\"ge_class\":\"Green\",\"hgmd.web.tag\":\"DM\",\"exon_in_hgmd\":\"[\\\"18/23\\\"]\",\"sample\":202205091715044,\"disease_description\":\"DISEASE: Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 1 (PEOA1) [MIM:157640]: A disorder characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged-red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism. {ECO:0000269|PubMed:11897778, ECO:0000269|PubMed:12210792, ECO:0000269|PubMed:15351195, ECO:0000269|PubMed:15534189, ECO:0000269|PubMed:17420318, ECO:0000269|PubMed:17846414, ECO:0000269|PubMed:18575922}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]: A severe form of progressive external ophthalmoplegia, a disorder characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. It is clinically more heterogeneous than the autosomal dominant forms. {ECO:0000269|PubMed:11431686, ECO:0000269|PubMed:12565911, ECO:0000269|PubMed:12707443, ECO:0000269|PubMed:12872260, ECO:0000269|PubMed:12975295, ECO:0000269|PubMed:14635118, ECO:0000269|PubMed:15349879, ECO:0000269|PubMed:15351195, ECO:0000269|PubMed:15477547, ECO:0000269|PubMed:15917273, ECO:0000269|PubMed:16401742, ECO:0000269|PubMed:16621917, ECO:0000269|PubMed:16634032, ECO:0000269|PubMed:16639411}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459]: A systemic disorder resulting from mitochondrial dysfunction associated with mitochondrial depletion in skeletal muscle and peripheral nerve tissue. The clinical triad of symptoms consists of sensory ataxic neuropathy, dysarthria, and ophthalmoparesis. However, the phenotype varies widely, even within the same family, and can also include myopathy, seizures, and hearing loss. {ECO:0000269|PubMed:12565911, ECO:0000269|PubMed:14745080, ECO:0000269|PubMed:15477547, ECO:0000269|PubMed:15824347, ECO:0000269|PubMed:15917273, ECO:0000269|PubMed:16080118, ECO:0000269|PubMed:16621917, ECO:0000269|PubMed:16639411, ECO:0000269|PubMed:16919951}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]: An autosomal recessive hepatocerebral syndrome due to mitochondrial dysfunction. The typical course of the disease includes severe developmental delay, intractable seizures, liver failure, and death in childhood. Refractory seizures, cortical blindness, progressive liver dysfunction, and acute liver failure after exposure to valproic acid are considered diagnostic features. The neuropathological hallmarks are neuronal loss, spongiform degeneration, and astrocytosis of the visual cortex. Liver biopsy results show steatosis, often progressing to cirrhosis. {ECO:0000269|PubMed:15122711, ECO:0000269|PubMed:15689359, ECO:0000269|PubMed:15929042, ECO:0000269|PubMed:16621917, ECO:0000269|PubMed:16639411, ECO:0000269|PubMed:18828154}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mitochondrial DNA depletion syndrome 4B (MTDPS4B) [MIM:613662]: An autosomal recessive progressive multisystem disorder due to mitochondrial dysfunction. It is clinically characterized by chronic gastrointestinal dysmotility and pseudo- obstruction, cachexia, progressive external ophthalmoplegia, axonal sensory ataxic neuropathy, and muscle weakness. {ECO:0000269|PubMed:12825077, ECO:0000269|PubMed:19307547}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:18828154}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spinocerebellar ataxia with epilepsy (SCAE) [MIM:607459]: An autosomal recessive syndrome characterized by headaches and/or seizures manifesting in childhood or adolescence, cerebellar and sensory ataxia, dysarthria, and myoclonus manifesting in early adulthood. Neuropathological findings include spinocerebellar degeneration associated with cortical neuronal degeneration in advanced cases. {ECO:0000269|PubMed:26942291}. Note=The disease is caused by mutations affecting the gene represented in this entry.; \",\"hgmd.codon.disease\":\"Lactic_acidosis\",\"chrom\":\"chr15\",\"gnomad.exome.sas\":\"2.28698e-04\",\"filter\":\"PASS\",\"codon\":\"Cgc/Tgc\",\"mim.inheritance\":\"[\\\"AR\\\",\\\"AD\\\"]\",\"depth\":\"460\",\"qual\":\"4952.64\",\"snv\":\"hg19:15:089864088:G:A\",\"create_at\":\"2022-05-20T07:48:49.846\",\"exon\":\"[\\\"18/23\\\",\\\"\\\",\\\"18/23\\\",\\\"\\\"]\",\"function_description\":\"FUNCTION: Involved in the replication of mitochondrial DNA. Associates with mitochondrial DNA.; \",\"mutationtaster.pred\":\"D&D\",\"reported\":\"[\\\"202111191715321:N046=VUS\\\",\\\"202205091715044:N046=VUS\\\"]\",\"service\":\"N046\"}"
    val testN046VUSVar1 = "{ \"ge_green\": \"Severe Paediatric Disorders | Severe Paediatric Disorders | Paediatric disorders | Paediatric disorders | Paediatric disorders | Paediatric disorders | IUGR and IGF abnormalities | IUGR and IGF abnormalities | Growth failure in early childhood | Fetal anomalies | DDG2P | Fetal anomalies | Growth failure in early childhood | Skeletal dysplasia | Skeletal dysplasia\", \"hgvsc\": \"[\\\"NM_014780.4:c.1672G>A\\\",\\\"NM_001168370.1:c.1924G>A\\\",\\\"\\\",\\\"\\\"]\", \"reference\": \"hg19\", \"ref\": \"C\", \"gnomad.exome.eas_kor\": \"2.61917e-04\", \"cadd.raw\": \"3.617880\", \"vaf\": \"0.520639147803\", \"mutationtaster.score\": \"0.996868&0.996868\", \"class_order\": \"60\", \"hgvsp\": \"[\\\"p.Asp558Asn\\\",\\\"p.Asp642Asn\\\",\\\"p.?\\\",\\\"p.?\\\"]\", \"splicing_distance\": \"0\", \"organism\": \"homo sapiens\", \"so_term\": \"[\\\"missense_variant\\\"]\", \"alt\": \"T\", \"cadd.pred\": \"24.6\", \"sift.pred\": \"deleterious\", \"gene.refgene\": \"CUL7\", \"spliceai_ds_max\": \"0.01\", \"lrt.score\": \"0.000030\", \"analysis\": \"01db4ff4-9689-47b0-b0d9-1659788912c5:22SS004:003\", \"gnomad.total\": \"3.97630124458e-06\", \"tags\": \"[\\\"candidate\\\",\\\"all\\\"]\", \"genotype\": \"0/1\", \"intervar.class\": \"Uncertain_significance\", \"gmd2256_af\": \"0.00022\", \"intervar.evidence.pv\": \"PM1&PM2\", \"polyphen.pred\": \"probably_damaging\", \"insilico_sanger\": \"Y\", \"polyphen.score\": \"1\", \"hgmd.hgvsp\": \"[\\\"p.Asp558Asn\\\"]\", \"effect_level\": \"MED\", \"fathmm.pred\": \"T&T\", \"strand\": \"false\", \"sift.score\": \"0\", \"pos\": \"43017298\", \"lrt.pred\": \"D\", \"hgmd.hgvsc\": \"[\\\"NM_014780.4:c.1672G>A\\\"]\", \"gnomad.exome.eas\": \"5.43656e-05\", \"class\": \"VUS\", \"fathmm.score\": \"-0.19&-0.19\", \"mim.disease\": \"3-M syndrome 1, 273750 (3), Autosomal recessive\", \"ge_class\": \"Green\", \"exon_in_hgmd\": \"[\\\"7/26\\\"]\", \"sample\": \"22SS004_20220802-171-5075_SS-03_I\", \"disease_description\": \"DISEASE: 3M syndrome 1 (3M1) [MIM:273750]: An autosomal recessive disorder characterized by severe pre- and postnatal growth retardation, facial dysmorphism, large head circumference, and normal intelligence and endocrine function. Skeletal changes include long slender tubular bones and tall vertebral bodies. {ECO:0000269|PubMed:16142236, ECO:0000269|PubMed:17675530, ECO:0000269|PubMed:23018678}. Note=The disease is caused by mutations affecting the gene represented in this entry.; \", \"chrom\": \"chr6\", \"gnomad.exome.sas\": \"0.00000e+00\", \"filter\": \"PASS\", \"codon\": \"Gac/Aac\", \"mim.inheritance\": \"[\\\"AR\\\"]\", \"depth\": \"751\", \"qual\": \"9326.64\", \"snv\": \"hg19:06:043017298:C:T\", \"create_at\": \"2022-08-16T13:11:43.596\", \"exon\": \"[\\\"7/26\\\",\\\"7/26\\\",\\\"\\\",\\\"\\\"]\", \"function_description\": \"FUNCTION: Core component of the 3M and Cul7-RING(FBXW8) complexes, which mediates the ubiquitination of target proteins. Core component of the 3M complex, a complex required to regulate microtubule dynamics and genome integrity. It is unclear how the 3M complex regulates microtubules, it could act by controlling the level of a microtubule stabilizer (PubMed:24793695). Interaction with CUL9 is required to inhibit CUL9 activity and ubiquitination of BIRC5 (PubMed:24793696). Core component of a Cul7-RING ubiquitin-protein ligase with FBXW8, which mediates ubiquitination and consequent degradation of target proteins such as GORASP1, IRS1 and MAP4K1/HPK1 (PubMed:21572988, PubMed:24362026). Ubiquitination of GORASP1 regulates Golgi morphogenesis and dendrite patterning in brain (PubMed:21572988). Mediates ubiquitination and degradation of IRS1 in a mTOR-dependent manner: the Cul7-RING(FBXW8) complex recognizes and binds IRS1 previously phosphorylated by S6 kinase (RPS6KB1 or RPS6KB2) (PubMed:18498745). The Cul7-RING(FBXW8) complex also mediates ubiquitination of MAP4K1/HPK1: recognizes and binds autophosphorylated MAP4K1/HPK1, leading to its degradation, thereby affecting cell proliferation and differentiation (PubMed:24362026). Acts as a regulator in trophoblast cell epithelial-mesenchymal transition and placental development (PubMed:20139075). Does not promote polyubiquitination and proteasomal degradation of p53/TP53 (PubMed:16547496, PubMed:17332328). While the Cul7-RING(FBXW8) and the 3M complexes are associated and involved in common processes, CUL7 and the Cul7-RING(FBXW8) complex may be have additional functions. {ECO:0000269|PubMed:16547496, ECO:0000269|PubMed:17332328, ECO:0000269|PubMed:18498745, ECO:0000269|PubMed:20139075, ECO:0000269|PubMed:21572988, ECO:0000269|PubMed:24362026, ECO:0000269|PubMed:24793695, ECO:0000269|PubMed:24793696}.; \", \"mutationtaster.pred\": \"D&D\" }"
    val testN046VUSVar2 = "{ \"ge_green\": \"Severe Paediatric Disorders | Severe Paediatric Disorders | Severe microcephaly | Paediatric disorders | Paediatric disorders | Paediatric disorders | Paediatric disorders | Ovarian cancer pertinent cancer susceptibility | Neurofibromatosis Type 1 | Neurofibromatosis Type 1 | Head and neck cancer pertinent cancer susceptibility | Haematological malignancies cancer susceptibility | Growth failure in early childhood | Growth failure in early childhood | Fetal anomalies | Fetal anomalies | DDG2P | Childhood solid tumours cancer susceptibility | Adult solid tumours cancer susceptibility | Adult solid tumours for rare disease | Adult solid tumours for rare disease | Childhood solid tumours cancer susceptibility | Confirmed Fanconi anaemia or Bloom syndrome | Confirmed Fanconi anaemia or Bloom syndrome | Cytopenias and congenital anaemias | Cytopenias and congenital anaemias | DDG2P | Haematological malignancies cancer susceptibility | Haematological malignancies for rare disease | Haematological malignancies for rare disease | Head and neck cancer pertinent cancer susceptibility | Inherited ovarian cancer (without breast cancer) | Inherited ovarian cancer (without breast cancer) | Limb disorders | Limb disorders | Ovarian cancer pertinent cancer susceptibility | Pigmentary skin disorders | Pigmentary skin disorders | Radial dysplasia | Radial dysplasia | Severe microcephaly | Tumour predisposition - childhood onset | Tumour predisposition - childhood onset\", \"hgvsc\": \"[\\\"NM_032043.3:c.787C>T\\\"]\", \"reference\": \"hg19\", \"ref\": \"G\", \"cadd.raw\": \"4.040743\", \"dbsnp\": \"rs1060501776\", \"vaf\": \"0.485119047619\", \"mutationtaster.score\": \"0.999986&0.999986\", \"class_order\": \"60\", \"hgvsp\": \"[\\\"p.Leu263Phe\\\"]\", \"splicing_distance\": \"0\", \"organism\": \"homo sapiens\", \"gnomad.genome.eas\": \"6.41026e-04\", \"so_term\": \"[\\\"missense_variant\\\"]\", \"alt\": \"A\", \"cadd.pred\": \"26.6\", \"sift.pred\": \"deleterious\", \"gene.refgene\": \"BRIP1\", \"spliceai_ds_max\": \"0.0\", \"lrt.score\": \"0.000000\", \"analysis\": \"01db4ff4-9689-47b0-b0d9-1659788912c5:22SS004:003\", \"gnomad.total\": \"3.18552497452e-05\", \"tags\": \"[\\\"candidate\\\",\\\"all\\\"]\", \"genotype\": \"0/1\", \"intervar.class\": \"Uncertain_significance\", \"krgdb_af\": \"0.000454545\", \"gmd2256_af\": \"0.00066\", \"clinvar.updated_class\": \"Uncertain significance\", \"intervar.evidence.pv\": \"PM1&PM2&PP3\", \"polyphen.pred\": \"probably_damaging\", \"insilico_sanger\": \"Y\", \"polyphen.score\": \"1\", \"hgmd.hgvsp\": \"[\\\"p.Leu263Phe\\\"]\", \"effect_level\": \"MED\", \"intervar.evidence.bv\": \"BP1\", \"clinvar.clndbn\": \"[\\\"Neoplasm_of_ovary&Fanconi_anemia_complementation_group_J&Hereditary_cancer-predisposing_syndrome&Familial_cancer_of_breast&not_specified&not_provided\\\"]\", \"fathmm.pred\": \"T&T\", \"strand\": \"false\", \"sift.score\": \"0\", \"pos\": \"59885959\", \"lrt.pred\": \"D\", \"hgmd.hgvsc\": \"[\\\"NM_032043.3:c.787C>T\\\"]\", \"clinvar.updated_review\": \"criteria provided, multiple submitters, no conflicts\", \"class\": \"VUS\", \"fathmm.score\": \"-1.08&-1.08\", \"clinvar.class\": \"Uncertain_significance\", \"clinvar.id\": \"407869\", \"mim.disease\": \"Fanconi anemia, complementation group J, 609054 (3) | {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant\", \"ge_class\": \"Green\", \"exon_in_hgmd\": \"[\\\"7/20\\\"]\", \"sample\": \"22SS004_20220802-171-5075_SS-03_I\", \"disease_description\": \"DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:11301010, ECO:0000269|PubMed:14983014}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group J (FANCJ) [MIM:609054]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:16116423, ECO:0000269|PubMed:16116424, ECO:0000269|PubMed:20639400}. Note=The disease is caused by mutations affecting the gene represented in this entry.; \", \"chrom\": \"chr17\", \"filter\": \"PASS\", \"codon\": \"Ctc/Ttc\", \"mim.inheritance\": \"[\\\"Somatic mutation, AD\\\"]\", \"depth\": \"672\", \"qual\": \"7983.64\", \"snv\": \"hg19:17:059885959:G:A\", \"create_at\": \"2022-08-16T13:11:43.597\", \"exon\": \"[\\\"7/20\\\"]\", \"function_description\": \"FUNCTION: DNA-dependent ATPase and 5' to 3' DNA helicase required for the maintenance of chromosomal stability. Acts late in the Fanconi anemia pathway, after FANCD2 ubiquitination. Involved in the repair of DNA double-strand breaks by homologous recombination in a manner that depends on its association with BRCA1. {ECO:0000269|PubMed:11301010, ECO:0000269|PubMed:14983014, ECO:0000269|PubMed:16116421, ECO:0000269|PubMed:16153896}.; \", \"mutationtaster.pred\": \"D&D\" }"
    val testN046VUSVar3 = "{ \"hgmd.mut\": \"ALT\", \"ge_green\": \"White matter disorders - childhood onset | White matter disorders - childhood onset | Silver Russell syndrome | Silver Russell syndrome | Severe microcephaly | Severe microcephaly | Paediatric disorders | Paediatric disorders | Paediatric disorders | Paediatric disorders | IUGR and IGF abnormalities | Intellectual disability | Hypotonic infant | Growth failure in early childhood | Fetal anomalies | DDG2P | Fetal anomalies | Growth failure in early childhood | Hypotonic infant | Intellectual disability | IUGR and IGF abnormalities | Severe Paediatric Disorders | Severe Paediatric Disorders\", \"hgvsc\": \"[\\\"NM_001291858.2:c.413G>A\\\",\\\"NM_000875.5:c.413G>A\\\"]\", \"reference\": \"hg19\", \"ref\": \"G\", \"cadd.raw\": \"4.559021\", \"vaf\": \"0.474103585657\", \"mutationtaster.score\": \"1&1\", \"class_order\": \"30\", \"hgvsp\": \"[\\\"p.Arg138Gln\\\"]\", \"splicing_distance\": \"0\", \"organism\": \"homo sapiens\", \"so_term\": \"[\\\"missense_variant\\\"]\", \"alt\": \"A\", \"cadd.pred\": \"32\", \"sift.pred\": \"deleterious\", \"gene.refgene\": \"IGF1R\", \"spliceai_ds_max\": \"0.0\", \"lrt.score\": \"0.003346\", \"analysis\": \"01db4ff4-9689-47b0-b0d9-1659788912c5:22SS004:003\", \"gnomad.total\": \"0\", \"tags\": \"[\\\"candidate\\\",\\\"all\\\"]\", \"genotype\": \"0/1\", \"intervar.class\": \"Uncertain_significance\", \"clinvar.updated_class\": \"protective\", \"hgmd.tag\": \"DM\", \"intervar.evidence.pv\": \"PM1&PM2&PP3\", \"hgmd.pmid\": \"14657428\", \"polyphen.pred\": \"probably_damaging\", \"insilico_sanger\": \"Y\", \"polyphen.score\": \"1\", \"hgmd.hgvsp\": \"[\\\"p.Arg138Gln\\\"]\", \"hgmd.web.literature\": \"{1. Abuzzahab (2003) N Engl J Med 349: 2211 PubMed: 14657428 IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. | Primary literature report | dm:original reference supporting inclusion | No comments}\", \"effect_level\": \"MED\", \"clinvar.clndbn\": \"[\\\"Growth_delay_due_to_insulin-like_growth_factor_I_resistance\\\"]\", \"fathmm.pred\": \".&.&T&T&T\", \"strand\": \"true\", \"sift.score\": \"0\", \"pos\": \"99251109\", \"lrt.pred\": \"N\", \"hgmd.hgvsc\": \"[\\\"NM_000875.5:c.413G>A\\\"]\", \"clinvar.updated_review\": \"no assertion criteria provided\", \"class\": \"DM\", \"fathmm.score\": \".&.&-1.3&-1.3&-1.3\", \"clinvar.class\": \"protective\", \"clinvar.id\": \"14790\", \"mim.disease\": \"Insulin-like growth factor I, resistance to, 270450 (3), Autosomal dominant, Autosomal recessive\", \"ge_class\": \"Green\", \"hgmd.web.tag\": \"DM\", \"exon_in_hgmd\": \"[\\\"2/21\\\"]\", \"sample\": \"22SS004_20220802-171-5075_SS-03_I\", \"disease_description\": \"DISEASE: Insulin-like growth factor 1 resistance (IGF1RES) [MIM:270450]: A disorder characterized by intrauterine growth retardation, poor postnatal growth and increased plasma IGF1 levels. {ECO:0000269|PubMed:14657428, ECO:0000269|PubMed:15928254, ECO:0000269|PubMed:25040157}. Note=The disease is caused by mutations affecting the gene represented in this entry.; \", \"hgmd.codon.disease\": \"Growth_retardation\", \"chrom\": \"chr15\", \"filter\": \"PASS\", \"codon\": \"cGg/cAg\", \"mim.inheritance\": \"[\\\"AD, AR\\\"]\", \"depth\": \"753\", \"qual\": \"8245.64\", \"snv\": \"hg19:15:099251109:G:A\", \"create_at\": \"2022-08-16T13:11:43.595\", \"exon\": \"[\\\"2/21\\\"]\", \"function_description\": \"FUNCTION: Receptor tyrosine kinase which mediates actions of insulin-like growth factor 1 (IGF1). Binds IGF1 with high affinity and IGF2 and insulin (INS) with a lower affinity. The activated IGF1R is involved in cell growth and survival control. IGF1R is crucial for tumor transformation and survival of malignant cell. Ligand binding activates the receptor kinase, leading to receptor autophosphorylation, and tyrosines phosphorylation of multiple substrates, that function as signaling adapter proteins including, the insulin-receptor substrates (IRS1/2), Shc and 14-3-3 proteins. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway and the Ras-MAPK pathway. The result of activating the MAPK pathway is increased cellular proliferation, whereas activating the PI3K pathway inhibits apoptosis and stimulates protein synthesis. Phosphorylated IRS1 can activate the 85 kDa regulatory subunit of PI3K (PIK3R1), leading to activation of several downstream substrates, including protein AKT/PKB. AKT phosphorylation, in turn, enhances protein synthesis through mTOR activation and triggers the antiapoptotic effects of IGFIR through phosphorylation and inactivation of BAD. In parallel to PI3K- driven signaling, recruitment of Grb2/SOS by phosphorylated IRS1 or Shc leads to recruitment of Ras and activation of the ras-MAPK pathway. In addition to these two main signaling pathways IGF1R signals also through the Janus kinase/signal transducer and activator of transcription pathway (JAK/STAT). Phosphorylation of JAK proteins can lead to phosphorylation/activation of signal transducers and activators of transcription (STAT) proteins. In particular activation of STAT3, may be essential for the transforming activity of IGF1R. The JAK/STAT pathway activates gene transcription and may be responsible for the transforming activity. JNK kinases can also be activated by the IGF1R. IGF1 exerts inhibiting activities on JNK activation via phosphorylation and inhibition of MAP3K5/ASK1, which is able to directly associate with the IGF1R.; \", \"mutationtaster.pred\": \"A&A\" }"
    val testN046VUSVar4 = "{ \"ge_green\": \"Severe Paediatric Disorders | Paediatric disorders | Paediatric disorders | Paediatric disorders | Neurofibromatosis Type 1 | Neurofibromatosis Type 1 | Inherited pancreatic cancer | Inherited ovarian cancer (without breast cancer) | Haematological malignancies cancer susceptibility | Growth failure in early childhood | Fetal anomalies | Familial breast cancer | DDG2P | DDG2P | ClinGen Gene Validity Curations | Childhood solid tumours cancer susceptibility | Breast cancer pertinent cancer susceptibility | Adult solid tumours cancer susceptibility | Adult solid tumours for rare disease | Adult solid tumours for rare disease | Breast cancer pertinent cancer susceptibility | Childhood solid tumours cancer susceptibility | ClinGen Gene Validity Curations | Confirmed Fanconi anaemia or Bloom syndrome | Confirmed Fanconi anaemia or Bloom syndrome | Cytopenias and congenital anaemias | Cytopenias and congenital anaemias | Familial breast cancer | Fetal anomalies | Growth failure in early childhood | Haematological malignancies cancer susceptibility | Haematological malignancies for rare disease | Haematological malignancies for rare disease | Inherited ovarian cancer (without breast cancer) | Inherited pancreatic cancer | Limb disorders | Limb disorders | Paediatric disorders | Pigmentary skin disorders | Pigmentary skin disorders | Radial dysplasia | Radial dysplasia | Severe Paediatric Disorders | Tumour predisposition - childhood onset | Tumour predisposition - childhood onset\", \"hgvsc\": \"[\\\"NM_024675.4:c.3236C>T\\\"]\", \"reference\": \"hg19\", \"ref\": \"G\", \"gnomad.exome.eas_kor\": \"0.00000e+00\", \"cadd.raw\": \"3.898178\", \"vaf\": \"0.523219814241\", \"mutationtaster.score\": \"0.751339\", \"class_order\": \"60\", \"hgvsp\": \"[\\\"p.Ala1079Val\\\"]\", \"splicing_distance\": \"0\", \"organism\": \"homo sapiens\", \"so_term\": \"[\\\"missense_variant\\\"]\", \"alt\": \"A\", \"cadd.pred\": \"25.8\", \"sift.pred\": \"deleterious\", \"gene.refgene\": \"PALB2\", \"spliceai_ds_max\": \"0.02\", \"lrt.score\": \"0.006845\", \"exac.eas\": \"0\", \"analysis\": \"01db4ff4-9689-47b0-b0d9-1659788912c5:22SS004:003\", \"gnomad.total\": \"3.97658586244e-06\", \"tags\": \"[\\\"candidate\\\",\\\"all\\\"]\", \"genotype\": \"0/1\", \"intervar.class\": \"Uncertain_significance\", \"krgdb_af\": \"0.000909091\", \"gmd2256_af\": \"0.00022\", \"clinvar.updated_class\": \"Uncertain significance\", \"intervar.evidence.pv\": \"PM1&PM2\", \"polyphen.pred\": \"possibly_damaging\", \"insilico_sanger\": \"Y\", \"polyphen.score\": \"0.947\", \"hgmd.hgvsp\": \"[\\\"p.Ala1079Val\\\"]\", \"effect_level\": \"MED\", \"intervar.evidence.bv\": \"BP1\", \"clinvar.clndbn\": \"[\\\"Hereditary_cancer-predisposing_syndrome&Familial_cancer_of_breast&not_provided\\\"]\", \"fathmm.pred\": \".&T\", \"strand\": \"false\", \"sift.score\": \"0.02\", \"pos\": \"23619299\", \"lrt.pred\": \"N\", \"ge_amber\": \"Severe microcephaly | Severe microcephaly | .\", \"hgmd.hgvsc\": \"[\\\"NM_024675.4:c.3236C>T\\\"]\", \"clinvar.updated_review\": \"criteria provided, multiple submitters, no conflicts\", \"gnomad.exome.eas\": \"0.00000e+00\", \"class\": \"VUS\", \"exac.sas\": \"0\", \"fathmm.score\": \".&2.27\", \"clinvar.class\": \"Uncertain_significance\", \"clinvar.id\": \"460984\", \"mim.disease\": \"{Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant | {Pancreatic cancer, susceptibility to, 3}, 613348 (3) | Fanconi anemia, complementation group N, 610832 (3)\", \"ge_class\": \"Green\", \"exon_in_hgmd\": \"[\\\"12/13\\\"]\", \"sample\": \"22SS004_20220802-171-5075_SS-03_I\", \"disease_description\": \"DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:17287723, ECO:0000269|PubMed:22241545, ECO:0000269|PubMed:28319063}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Breast cancer susceptibility is strongly associated with PALB2 truncating mutations. Conversely, rare missense mutations do not strongly influence breast cancer risk (PubMed:22241545). {ECO:0000269|PubMed:22241545}.; DISEASE: Fanconi anemia complementation group N (FANCN) [MIM:610832]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:17200672}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 3 (PNCA3) [MIM:613348]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:19264984}. Note=The disease is caused by mutations affecting the gene represented in this entry.; \", \"chrom\": \"chr16\", \"gnomad.exome.sas\": \"0.00000e+00\", \"filter\": \"PASS\", \"codon\": \"gCc/gTc\", \"mim.inheritance\": \"[\\\"Somatic mutation, AD\\\"]\", \"depth\": \"646\", \"qual\": \"8236.64\", \"snv\": \"hg19:16:023619299:G:A\", \"create_at\": \"2022-08-16T13:11:43.596\", \"exon\": \"[\\\"12/13\\\"]\", \"function_description\": \"FUNCTION: Plays a critical role in homologous recombination repair (HRR) through its ability to recruit BRCA2 and RAD51 to DNA breaks (PubMed:16793542, PubMed:19423707, PubMed:19369211, PubMed:22941656, PubMed:24141787, PubMed:28319063). Strongly stimulates the DNA strand-invasion activity of RAD51, stabilizes the nucleoprotein filament against a disruptive BRC3-BRC4 polypeptide and helps RAD51 to overcome the suppressive effect of replication protein A (RPA) (PubMed:20871615). Functionally cooperates with RAD51AP1 in promoting of D-loop formation by RAD51 (PubMed:20871616). Serves as the molecular scaffold in the formation of the BRCA1-PALB2-BRCA2 complex which is essential for homologous recombination (PubMed:19369211). Via its WD repeats is proposed to scaffold a HR complex containing RAD51C and BRCA2 which is thought to play a role in HR-mediated DNA repair (PubMed:24141787). Essential partner of BRCA2 that promotes the localization and stability of BRCA2 (PubMed:16793542). Also enables its recombinational repair and checkpoint functions of BRCA2 (PubMed:16793542). May act by promoting stable association of BRCA2 with nuclear structures, allowing BRCA2 to escape the effects of proteasome-mediated degradation (PubMed:16793542). Binds DNA with high affinity for D loop, which comprises single- stranded, double-stranded and branched DNA structures (PubMed:20871616). May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with BRCA2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity (PubMed:24485656). {ECO:0000269|PubMed:16793542, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:19423707, ECO:0000269|PubMed:20871615, ECO:0000269|PubMed:20871616, ECO:0000269|PubMed:22941656, ECO:0000269|PubMed:24141787, ECO:0000269|PubMed:24485656, ECO:0000269|PubMed:28319063}.; \", \"mutationtaster.pred\": \"N\" }"
    val testN100LPVVar1 = "{\"insilico_sanger\": \"Y\", \"ge_green\": \"Severe Paediatric Disorders | Pulmonary arterial hypertension | Cerebral vascular malformations | Bleeding and platelet disorders | Cerebral vascular malformations | Hereditary haemorrhagic telangiectasia | Hereditary haemorrhagic telangiectasia | Inherited bleeding disorders | Inherited bleeding disorders | Pulmonary arterial hypertension | Severe Paediatric Disorders | Vascular skin disorders | Vascular skin disorders\", \"hgmd.hgvsp\": \"[\\\"p.Ile467SerfsTer31\\\"]\", \"effect_level\": \"HIGH\", \"hgvsc\": \"[\\\"NM_001278138.1:c.833_852dup\\\",\\\"NM_000118.3:c.1379_1398dup\\\",\\\"\\\",\\\"NM_001114753.2:c.1379_1398dup\\\",\\\"\\\",\\\"\\\",\\\"\\\",\\\"NR_136302.1:n.1568+35_1568+54dup\\\"]\", \"reference\": \"hg19\", \"ref\": \"T\", \"strand\": \"true\", \"pos\": \"130581024\", \"hgmd.hgvsc\": \"[\\\"NM_000118.3:c.1379_1398dup\\\"]\", \"vaf\": \"0.44\", \"hgvsp\": \"[\\\"p.Ile285SerfsTer31\\\",\\\"p.Ile467SerfsTer31\\\",\\\"p.?\\\",\\\"p.Ile467SerfsTer31\\\",\\\"p.?\\\",\\\"p.?\\\",\\\"p.?\\\",\\\"p.?\\\"]\", \"splicing_distance\": \"0\", \"organism\": \"homo sapiens\", \"mim.disease\": \"Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3), Autosomal dominant\", \"ge_class\": \"Green\", \"so_term\": \"[\\\"frameshift_variant\\\"]\", \"alt\": \"TGGTGTTGGAGGCCTGGAGGA\", \"gene.refgene\": \"ENG\", \"spliceai_ds_max\": \"0.0\", \"exon_in_hgmd\": \"[\\\"11/14\\\"]\", \"analysis\": \"01db4ff4-9689-47b0-b0d9-1659788912c5:22ST014:005\", \"sample\": \"22ST014_20220614-171-5183_STK-05_I\", \"disease_description\": \"DISEASE: Telangiectasia, hereditary hemorrhagic, 1 (HHT1) [MIM:187300]: A multisystemic vascular dysplasia leading to dilation of permanent blood vessels and arteriovenous malformations of skin, mucosa, and viscera. The disease is characterized by recurrent epistaxis and gastro-intestinal hemorrhage. Visceral involvement includes arteriovenous malformations of the lung, liver, and brain. {ECO:0000269|PubMed:10545596, ECO:0000269|PubMed:10625079, ECO:0000269|PubMed:10982033, ECO:0000269|PubMed:15024723, ECO:0000269|PubMed:15712270, ECO:0000269|PubMed:16525724, ECO:0000269|PubMed:16752392, ECO:0000269|PubMed:20414677, ECO:0000269|PubMed:7894484, ECO:0000269|PubMed:9157574, ECO:0000269|PubMed:9245986, ECO:0000269|PubMed:9554745}. Note=The disease is caused by mutations affecting the gene represented in this entry.; \", \"gnomad.total\": \"0\", \"tags\": \"[\\\"all\\\",\\\"candidate\\\"]\", \"genotype\": \"0/1\", \"chrom\": \"chr9\", \"filter\": \"PASS\", \"codon\": \"-/TCCTCCAGGCCTCCAACACC\", \"mim.inheritance\": \"[\\\"AD\\\"]\", \"depth\": \"150\", \"qual\": \"2469.6\", \"snv\": \"hg19:09:130581024:T:TGGTGTTGGAGGCCTGGAGGA\", \"create_at\": \"2022-06-21T17:22:01.567\", \"exon\": \"[\\\"11/15\\\",\\\"11/14\\\",\\\"\\\",\\\"11/15\\\",\\\"\\\",\\\"\\\",\\\"\\\",\\\"\\\"]\", \"function_description\": \"FUNCTION: Vascular endothelium glycoprotein that plays an important role in the regulation of angiogenesis (PubMed:21737454, PubMed:23300529). Required for normal structure and integrity of adult vasculature (PubMed:7894484). Regulates the migration of vascular endothelial cells (PubMed:17540773). Required for normal extraembryonic angiogenesis and for embryonic heart development (By similarity). May regulate endothelial cell shape changes in response to blood flow, which drive vascular remodeling and establishment of normal vascular morphology during angiogenesis (By similarity). May play a critical role in the binding of endothelial cells to integrins and/or other RGD receptors (PubMed:1692830). Acts as TGF-beta coreceptor and is involved in the TGF-beta/BMP signaling cascade that ultimately leads to the activation of SMAD transcription factors (PubMed:8370410, PubMed:21737454, PubMed:22347366, PubMed:23300529). Required for GDF2/BMP9 signaling through SMAD1 in endothelial cells and modulates TGFB1 signaling through SMAD3 (PubMed:21737454, PubMed:22347366, PubMed:23300529). {ECO:0000250|UniProtKB:Q63961, ECO:0000269|PubMed:17540773, ECO:0000269|PubMed:21737454, ECO:0000269|PubMed:23300529, ECO:0000269|PubMed:7894484, ECO:0000269|PubMed:8370410, ECO:0000305|PubMed:1692830}.; \", \"class_order\": \"10\", \"class\": \"PVS1\" }"
    val testN100LPVVar2 = "{ \"hgmd.mut\": \"ALT\", \"ge_green\": \"Retinal disorders | Paediatric disorders | Paediatric disorders | Fetal anomalies | DDG2P | Familial cerebral small vessel disease | Familial cerebral small vessel disease | Fetal anomalies | Retinal disorders | Severe Paediatric Disorders | Severe Paediatric Disorders\", \"af_1000g_eas\": \"0.001\", \"hgvsc\": \"[\\\"NM_001351800.1:c.2507C>T\\\",\\\"NM_001171.5:c.2849C>T\\\",\\\"NR_147784.1:n.2711C>T\\\"]\", \"reference\": \"hg19\", \"ref\": \"G\", \"gnomad.exome.eas_kor\": \"1.33958e-03\", \"cadd.raw\": \"1.673473\", \"dbsnp\": \"rs190557767\", \"af_1000g_sas\": \"0\", \"vaf\": \"0.51404494382\", \"mutationtaster.score\": \"1\", \"hgvsp\": \"[\\\"p.Ala836Val\\\",\\\"p.Ala950Val\\\",\\\"p.?\\\"]\", \"splicing_distance\": \"0\", \"organism\": \"homo sapiens\", \"gnomad.genome.eas\": \"3.20513e-03\", \"so_term\": \"[\\\"missense_variant\\\"]\", \"alt\": \"A\", \"cadd.pred\": \"17.27\", \"sift.pred\": \"tolerated\", \"gene.refgene\": \"ABCC6\", \"spliceai_ds_max\": \"0.08\", \"lrt.score\": \"0.614505\", \"exac.eas\": \"0.00247\", \"analysis\": \"01db4ff4-9689-47b0-b0d9-1659788912c5:22ST014:005\", \"gnomad.total\": \"9.01932842081e-05\", \"tags\": \"[\\\"all\\\",\\\"candidate\\\"]\", \"genotype\": \"0/1\", \"intervar.class\": \"Uncertain_significance\", \"krgdb_af\": \"0.00181818\", \"gmd2256_af\": \"0.00222\", \"hgmd.tag\": \"DM?\", \"intervar.evidence.pv\": \"PM1&PM2\", \"hgmd.pmid\": \"19284998\", \"polyphen.pred\": \"benign\", \"insilico_sanger\": \"Y\", \"polyphen.score\": \"0.001\", \"hgmd.hgvsp\": \"[\\\"p.Ala950Val\\\"]\", \"hgmd.web.literature\": \"{1. Sato (2009) Biochem Biophys Res Commun 380: 548 PubMed: 19284998 Novel mutations of ABCC6 gene in Japanese patients with Angioid streaks. | Primary literature report | dmq:original reference supporting inclusion either not conclusive or later additional evidence points to uncertainty | No comments}\", \"effect_level\": \"MED\", \"intervar.evidence.bv\": \"BP4\", \"fathmm.pred\": \"D\", \"strand\": \"false\", \"sift.score\": \"0.39\", \"pos\": \"16263649\", \"lrt.pred\": \"N\", \"ge_amber\": \"Rare genetic inflammatory skin disorders | . | Rare genetic inflammatory skin disorders\", \"wes_als312_af\": \"0.00481\", \"hgmd.hgvsc\": \"[\\\"NM_001171.5:c.2849C>T\\\"]\", \"gnomad.exome.eas\": \"1.06731e-03\", \"exac.sas\": \"0\", \"fathmm.score\": \"-3.52\", \"mim.disease\": \"Pseudoxanthoma elasticum, 264800 (3), Autosomal recessive | Arterial calcification, generalized, of infancy, 2, 614473 (3), Autosomal recessive | Pseudoxanthoma elasticum, forme fruste, 177850 (3), Autosomal dominant\", \"ge_class\": \"Green\", \"hgmd.web.tag\": \"DM?\", \"exon_in_hgmd\": \"[\\\"22/31\\\"]\", \"sample\": \"22ST014_20220614-171-5183_STK-05_I\", \"disease_description\": \"DISEASE: Pseudoxanthoma elasticum (PXE) [MIM:264800]: A multisystem disorder characterized by accumulation of mineralized and fragmented elastic fibers in the skin, vascular walls, and Burch membrane in the eye. Clinically, patients exhibit characteristic lesions of the posterior segment of the eye including peau d'orange, angioid streaks, and choroidal neovascularizations, of the skin including soft, ivory colored papules in a reticular pattern that predominantly affect the neck and large flexor surfaces, and of the cardiovascular system with peripheral and coronary arterial occlusive disease as well as gastrointestinal bleedings. {ECO:0000269|PubMed:10811882, ECO:0000269|PubMed:10835642, ECO:0000269|PubMed:10954200, ECO:0000269|PubMed:11427982, ECO:0000269|PubMed:11536079, ECO:0000269|PubMed:11702217, ECO:0000269|PubMed:11880368, ECO:0000269|PubMed:15086542, ECO:0000269|PubMed:15098239, ECO:0000269|PubMed:15459974, ECO:0000269|PubMed:16086317, ECO:0000269|PubMed:17617515, ECO:0000269|PubMed:19339160, ECO:0000269|PubMed:20034067, ECO:0000269|PubMed:25615550}. Note=The disease is caused by mutations affecting the gene represented in this entry. Homozygous or compound heterozygous ABCC6 mutations have been found in the overwhelming majority of cases. Individuals carrying heterozygous mutations express limited manifestations of the pseudoxanthoma elasticum phenotype.; DISEASE: Arterial calcification of infancy, generalized, 2 (GACI2) [MIM:614473]: A severe autosomal recessive disorder characterized by calcification of the internal elastic lamina of muscular arteries and stenosis due to myointimal proliferation. The disorder is often fatal within the first 6 months of life because of myocardial ischemia resulting in refractory heart failure. {ECO:0000269|PubMed:22209248}. Note=The disease is caused by mutations affecting the gene represented in this entry.; \", \"hgmd.codon.disease\": \"Angioid_streaks\", \"chrom\": \"chr16\", \"gnomad.exome.sas\": \"0.00000e+00\", \"filter\": \"PASS\", \"codon\": \"gCa/gTa\", \"mim.inheritance\": \"[\\\"AR\\\",\\\"AD\\\"]\", \"depth\": \"356\", \"qual\": \"4012.64\", \"snv\": \"hg19:16:016263649:G:A\", \"create_at\": \"2022-06-21T17:22:01.577\", \"exon\": \"[\\\"22/31\\\",\\\"22/31\\\",\\\"21/29\\\"]\", \"function_description\": \"FUNCTION: Isoform 1: May participate directly in the active transport of drugs into subcellular organelles or influence drug distribution indirectly. Transports glutathione conjugates as leukotriene-c4 (LTC4) and N-ethylmaleimide S-glutathione (NEM-GS). {ECO:0000269|PubMed:11880368}.; \", \"mutationtaster.pred\": \"N\", \"class_order\": \"35\", \"class\": \"DM?\" }"
    val testN100LPVVar3 = "{ \"insilico_sanger\": \"Y\", \"ge_green\": \"White matter disorders - childhood onset | White matter disorders - childhood onset | White matter disorders - childhood onset | White matter disorders - childhood onset | White matter disorders - adult onset | White matter disorders - adult onset | Unexplained paediatric onset end-stage renal disease | Unexplained paediatric onset end-stage renal disease | Severe Paediatric Disorders | Renal superpanel - narrow | Renal superpanel - narrow | Renal superpanel - narrow | Renal superpanel - broad | Renal superpanel - broad | Renal superpanel - broad | Renal superpanel - broad | Renal superpanel - broad | Paediatric disorders | Paediatric disorders | Paediatric disorders | Paediatric disorders | Intracerebral calcification disorders | Intracerebral calcification disorders | Intellectual disability | Intellectual disability | Hypotonic infant | Hypotonic infant | Hydrocephalus | Haematuria | Genetic epilepsy syndromes | Fetal anomalies | DDG2P | DDG2P | Cystic kidney disease | Cataracts | Anophthalmia or microphthalmia | Cataracts | Cystic kidney disease | Cystic renal disease | Cystic renal disease | Familial cerebral small vessel disease | Familial cerebral small vessel disease | Fetal anomalies | Genetic epilepsy syndromes | Haematuria | Hydrocephalus | Renal superpanel - broad | Renal superpanel - narrow | Retinal disorders | Retinal disorders | Severe Paediatric Disorders | Structural eye disease | Structural eye disease | White matter disorders and cerebral calcification - narrow panel | White matter disorders and cerebral calcification - narrow panel\", \"hgmd.hgvsp\": \"[\\\"p.?\\\"]\", \"effect_level\": \"MED\", \"hgvsc\": \"[\\\"NM_001845.6:c.958-5del\\\",\\\"NM_001303110.2:c.958-5del\\\"]\", \"reference\": \"hg19\", \"ref\": \"CA\", \"gnomad.exome.eas_kor\": \"2.09534e-03\", \"strand\": \"false\", \"pos\": \"110855958\", \"ge_amber\": \"Neuromuscular disorders | Hypotonic infant | Hypotonic infant | Congenital muscular dystrophy | . | Congenital muscular dystrophy | Neuromuscular disorders\", \"dbsnp\": \"rs749003041\", \"hgmd.hgvsc\": \"[\\\"NM_001845.6:c.958-5del\\\"]\", \"vaf\": \"0.482876712329\", \"gnomad.exome.eas\": \"4.34924e-04\", \"hgvsp\": \"[\\\"p.?\\\"]\", \"exac.sas\": \"0\", \"splicing_distance\": \"5\", \"organism\": \"homo sapiens\", \"gnomad.genome.eas\": \"6.41026e-04\", \"mim.disease\": \"?Retinal arteries, tortuosity of, 180000 (3), Autosomal dominant | {Hemorrhage, intracerebral, susceptibility to}, 614519 (3) | Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3), Autosomal dominant | Microangiopathy and leukoencephalopathy, pontine, autosomal dominant, 618564 (3), Autosomal dominant | Brain small vessel disease with or without ocular anomalies, 175780 (3), Autosomal dominant\", \"ge_class\": \"Green\", \"so_term\": \"[\\\"splice_region_variant\\\",\\\"intron_variant\\\"]\", \"alt\": \"C\", \"gene.refgene\": \"COL4A1\", \"spliceai_ds_max\": \"0.09\", \"exac.eas\": \"0.000462\", \"analysis\": \"01db4ff4-9689-47b0-b0d9-1659788912c5:22ST014:005\", \"sample\": \"22ST014_20220614-171-5183_STK-05_I\", \"disease_description\": \"DISEASE: Brain small vessel disease with or without ocular anomalies (BSVD) [MIM:607595]: An autosomal dominant disease characterized by weakening of the blood vessels in the brain and retinal arteriolar tortuosity. In affected individuals, stroke is often the first symptom and is usually caused by bleeding in the brain (hemorrhagic stroke) rather than a lack of blood flow in the brain (ischemic stroke). Patients also have leukoencephalopathy and may experience seizures and migraine headaches accompanied by visual sensations known as auras. {ECO:0000269|PubMed:16598045, ECO:0000269|PubMed:17379824, ECO:0000269|PubMed:17696175, ECO:0000269|PubMed:19477666, ECO:0000269|PubMed:20385946, ECO:0000269|PubMed:22574627, ECO:0000269|PubMed:23394911, ECO:0000269|PubMed:24628545}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hereditary angiopathy with nephropathy aneurysms and muscle cramps (HANAC) [MIM:611773]: The clinical renal manifestations include hematuria and bilateral large cysts. Histologic analysis revealed complex basement membrane defects in kidney and skin. The systemic angiopathy appears to affect both small vessels and large arteries. {ECO:0000269|PubMed:18160688, ECO:0000269|PubMed:20818663}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Porencephaly 1 (POREN1) [MIM:175780]: A neurologic disorder characterized by a fluid-filled cysts or cavities within the cerebral hemispheres, neurologic manifestations, facial paresis, and visual defects. Affected individuals typically have hemiplegia, seizures, and intellectual disability. Porencephaly type 1 is usually unilateral and results from focal destructive lesions such as fetal vascular occlusion or birth trauma. {ECO:0000269|PubMed:15905400, ECO:0000269|PubMed:16107487, ECO:0000269|PubMed:19194877}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Intracerebral hemorrhage (ICH) [MIM:614519]: A pathological condition characterized by bleeding into one or both cerebral hemispheres including the basal ganglia and the cerebral cortex. It is often associated with hypertension and craniocerebral trauma. Intracerebral bleeding is a common cause of stroke. {ECO:0000269|PubMed:22522439}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Tortuosity of retinal arteries (RATOR) [MIM:180000]: A disease characterized by marked tortuosity of second- and third- order retinal arteries with normal first-order arteries and venous system. Most patients manifest variable degrees of symptomatic transient vision loss due to retinal hemorrhage following minor stress or trauma. {ECO:0000269|PubMed:25228067}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Schizencephaly (SCHZC) [MIM:269160]: Extremely rare human congenital disorder characterized by a full-thickness cleft within the cerebral hemispheres. These clefts are lined with gray matter and most commonly involve the parasylvian regions. Large portions of the cerebral hemispheres may be absent and replaced by cerebro- spinal fluid. {ECO:0000269|PubMed:23225343}. Note=The disease is caused by mutations affecting the gene represented in this entry.; \", \"gnomad.total\": \"3.53867059223e-05\", \"tags\": \"[\\\"all\\\",\\\"candidate\\\"]\", \"genotype\": \"0/1\", \"chrom\": \"chr13\", \"gnomad.exome.sas\": \"0.00000e+00\", \"filter\": \"PASS\", \"krgdb_af\": \"0.000909091\", \"gmd2256_af\": \"0.00199\", \"mim.inheritance\": \"[\\\"AD\\\"]\", \"depth\": \"292\", \"qual\": \"3921.6\", \"snv\": \"hg19:13:110855958:CA:C\", \"create_at\": \"2022-06-21T17:22:01.573\", \"function_description\": \"FUNCTION: Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen. {ECO:0000250|UniProtKB:P02463}.; \", \"class_order\": \"60\", \"class\": \"VUS\" }"
    val testN100LPVVar4 = "{ \"mgi_wes151_af\": \"0.00662\", \"ge_green\": \"Cerebral vascular malformations\", \"af_1000g_eas\": \"0.001\", \"hgvsc\": \"[\\\"NM_001256071.3:c.9767C>T\\\",\\\"\\\"]\", \"reference\": \"hg19\", \"ref\": \"C\", \"gnomad.exome.eas_kor\": \"3.92876e-03\", \"cadd.raw\": \"0.902858\", \"dbsnp\": \"rs529113475\", \"af_1000g_sas\": \"0\", \"vaf\": \"0.4463840399\", \"mutationtaster.score\": \"1&1&1\", \"hgvsp\": \"[\\\"p.Ser3256Leu\\\",\\\"p.?\\\"]\", \"splicing_distance\": \"0\", \"organism\": \"homo sapiens\", \"gnomad.genome.eas\": \"1.28205e-03\", \"so_term\": \"[\\\"missense_variant\\\"]\", \"alt\": \"T\", \"cadd.pred\": \"12.08\", \"sift.pred\": \"tolerated\", \"gene.refgene\": \"RNF213\", \"spliceai_ds_max\": \"0.0\", \"lrt.score\": \"0.785683\", \"exac.eas\": \"0.00231\", \"analysis\": \"01db4ff4-9689-47b0-b0d9-1659788912c5:22ST014:005\", \"gnomad.total\": \"0.000155625508436\", \"tags\": \"[\\\"all\\\",\\\"candidate\\\"]\", \"genotype\": \"0/1\", \"intervar.class\": \"Likely_benign\", \"krgdb_af\": \"0.00454545\", \"gmd2256_af\": \"0.00465\", \"clinvar.updated_class\": \"Uncertain significance\", \"polyphen.pred\": \"benign\", \"insilico_sanger\": \"Y\", \"wes300_af\": \"0.00667\", \"polyphen.score\": \"0\", \"hgmd.hgvsp\": \"[\\\"p.Ser3256Leu\\\"]\", \"effect_level\": \"MED\", \"intervar.evidence.bv\": \"BP1&BP4\", \"clinvar.clndbn\": \"[\\\"not_provided\\\"]\", \"fathmm.pred\": \"T&T\", \"strand\": \"false\", \"sift.score\": \"1\", \"pos\": \"78321902\", \"lrt.pred\": \"N\", \"wes_als312_af\": \"0.00321\", \"hgmd.hgvsc\": \"[\\\"NM_001256071.3:c.9767C>T\\\"]\", \"clinvar.updated_review\": \"criteria provided, single submitter\", \"gnomad.exome.eas\": \"2.12072e-03\", \"exac.sas\": \"0\", \"fathmm.score\": \"2.43&2.43\", \"clinvar.class\": \"Uncertain_significance\", \"clinvar.id\": \"597193\", \"mim.disease\": \"{Moyamoya disease 2, susceptibility to}, 607151 (3), Autosomal dominant, Autosomal recessive\", \"ge_class\": \"Green\", \"exon_in_hgmd\": \"[\\\"29/68\\\"]\", \"sample\": \"22ST014_20220614-171-5183_STK-05_I\", \"disease_description\": \"DISEASE: Moyamoya disease 2 (MYMY2) [MIM:607151]: A progressive cerebral angiopathy characterized by bilateral intracranial carotid artery stenosis and telangiectatic vessels in the region of the basal ganglia. The abnormal vessels resemble a 'puff of smoke' (moyamoya) on cerebral angiogram. Affected individuals can develop transient ischemic attacks and/or cerebral infarction, and rupture of the collateral vessels can cause intracranial hemorrhage. Hemiplegia of sudden onset and epileptic seizures constitute the prevailing presentation in childhood, while subarachnoid bleeding occurs more frequently in adults. {ECO:0000269|PubMed:21048783, ECO:0000269|PubMed:21799892, ECO:0000269|PubMed:23110205, ECO:0000269|PubMed:23994138, ECO:0000269|PubMed:25278557, ECO:0000269|PubMed:25956231, ECO:0000269|PubMed:26126547, ECO:0000269|PubMed:26198278, ECO:0000269|PubMed:27736983}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving RNF213 is associated with anaplastic large-cell lymphoma (ALCL). Translocation t(2;17)(p23;q25) with ALK. {ECO:0000269|PubMed:12112524}.; \", \"chrom\": \"chr17\", \"gnomad.exome.sas\": \"3.26627e-05\", \"filter\": \"PASS\", \"codon\": \"tCg/tTg\", \"mim.inheritance\": \"[\\\"AD, AR\\\"]\", \"depth\": \"401\", \"qual\": \"4161.64\", \"snv\": \"hg19:17:078321902:C:T\", \"create_at\": \"2022-06-21T17:22:01.580\", \"exon\": \"[\\\"29/68\\\",\\\"\\\"]\", \"function_description\": \"FUNCTION: E3 ubiquitin-protein ligase involved in angiogenesis (PubMed:21799892, PubMed:26278786, PubMed:26766444, PubMed:26126547). Involved in the non-canonical Wnt signaling pathway in vascular development: acts by mediating ubiquitination and degradation of FLNA and NFATC2 downstream of RSPO3, leading to inhibit the non-canonical Wnt signaling pathway and promoting vessel regression (PubMed:26766444). Also has ATPase activity (PubMed:24658080, PubMed:26126547). {ECO:0000269|PubMed:21799892, ECO:0000269|PubMed:24658080, ECO:0000269|PubMed:26126547, ECO:0000269|PubMed:26278786, ECO:0000269|PubMed:26766444}.; \", \"mutationtaster.pred\": \"N&N&N\", \"class_order\": \"60\", \"class\": \"VUS\" }"
}




